Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: The Cherokee Diabetes Study

Annals of Epidemiology

Volumn 15, Issue 5, 2005, Pages 390-397

  Wang, Wenyu ^a   Lee, Elisa T ^a   Alaupovic, Petar ^b   Blackett, Piers ^c   Blevins, Kathleen S ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Adolescents; Cardiovascular Disease; Cherokee Indians; Children; Lipoprotein (a); The Cherokee Diabetes Study; Young Adults

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE MONITORING; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; INDIAN; INHERITANCE; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 17444378616     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2005.01.003     Document Type: Article

References (48)

1. K. Berg A new serum type system in man: The Lp system Acta Pathol Microbiol Scand 59 1963 369 382
2. G.M. Fless, M.E. ZumMallen, and A.M. Scanu Physiochemical properties of apolipoprotein (a) and lipoprotein (a) derived from the dissociation of human plasma lipoprotein (a) J Biol Chem 261 1986 8712 8718
3. O. Ziegler, B. Guerci, H. Candiloros, and P. Drouin Lipoprotein (a) and diabetes mellitus Diabete et Metabolisme 21 1995 127 138
4. R. Couderc, and M. Maachi Lipoprotein (a), a cardiovascular risk factor: Importance of its determination in current clinical practice Journal des Maladies Vasculaires 23 1998 165 175
5. J. Kreuzer, M.B. Lloyd, D. Bok, G.M. Fless, A.M. Scanu, and A.J. Lusis Lipoprotein (a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall Chemistry & Physics of Lipids 67-68 1994 175 190
6. C. Falco, A. Estelles, J. Dalmau, F. Espana, and J. Aznar Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity-study in families with high lipoprotein (a) levels Thrombosis & Haemostasis 79 1998 818 823
7. A. Estelles, A. Cano, C. Falco, F. Espana, J. Gilabert, and S. Grancha Lipoprotein (a) levels and isoforms and fibrinolytic activity in postmenopause-influence of hormone replacement therapy Thrombosis & Haemostasis 81 1999 104 110
8. W.H. Frishman Biologic markers as predictors of cardiovascular disease Am J Med 104 1998 18S 27S
9. S. Oparil, and A. Oberman Nontraditional cardiovascular risk factors Am J Med Sci 317 1999 193 207
10. E. Boerwinkle Genetics of plasma lipoprotein (a) concentrations Curr Opin Lipidol 3 1992 128 136
11. S.J. Hasstedt, and R.R. Williams Three alleles for quantitative Lp(a) Genet Epidemiol 3 1986 53 55
12. L. Iselius, G.H. Dahlen, U. DeFaire, and T. Lundman Complex segregation analysis of the Lp(a)/pre-beta1-lipoprotein trait Clin Genet 20 1981 147 151
13. B.V. Howard, N.A. Le, J.D. Belcher, J.M. Flack, D.R. Jacobs, and C.E. Lewis Concentrations of Lp(a) in black and white young adults: Relations to risk factors for cardiovascular disease Ann Epidemiol 4 1994 341 350
14. J.R. Guyton, G.H. Dahlen, W. Patsch, J.A. Kautz, and A.M. Gotto Jr. Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B Arteriosclerosis 5 1985 265 272
15. H.J. Parra, I. Luyeye, C. Bouramoue, C. Demarquilly, and J.C. Fruchart Black-white differences in serum Lp(a) lipoprotein levels Clin Chim Acta 167 1987 27 31
16. I.B. Sundell, T.K. Nilsson, G. Hallmans, G. Heelsten, and G.H. Dahlen Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a North Swedish population Atherosclerosis 80 1989 9 16
17. J.J. Albers, H.M. Taggart, D. Appelbaum-Bowden, S. Haffner, C.H. Chesnut, and W.R. Hazzard Reduction of the lecithin-cholesterol acetyl transferase, apolipoprotein D, and the Lp(a) lipoprotein with the anabolic steroid stanozolol Biochim Biophys Acta 795 1984 293 296
18. A. Gurakar, J.M. Hoeg, G. Kostner, N.M. Papadopoulos, and H.B. Brewer Jr. Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment Atherosclerosis 57 1985 293 301
19. L.A. Carlson, A. Hamsten, and A. Asplund Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid J Intern Med 226 1989 271 276
20. E. Farish, H.A. Rolton, J.F. Barnes, and D.M. Hart Lipoprotein(a) concentrations in postmenopausal women taking norethisterone BMJ 303 1991 694 695
21. R. Zechner, G. Desoye, M.O. Schweditsch, K.P. Pfeiffer, and G.M. Kostner Fluctuations of plasma lipoprotein-a concentrations during pregnancy and post partum Metabolism 35 1986 333 336
22. M. Davies, G. Rayman, and J. Day Increased incidence of coronary disease in people with impaired glucose tolerance: Link with increased lipoprotein (a) concentrations? BMJ 304 1992 1610 1611
23. H. Schriewer, G. Assmann, M. Sandkamp, and H. Schulte The relationship of Lp(a) to risk factors of coronary heart disease: Initial results of the prospective epidemiological study on company employees in Westfalia J Clin Chem Clin Biochem 22 1984 591 596
24. S.Y. Kimm, A. Pasagian-Macaulay, C.E. Aston, A.E. McAllister, N.W. Glynn, and M.I. Kamboh Correlates of lipoprotein(a) levels in a biracial cohort of young girls: The NHLBI Growth and Health Study J Pediatr 135 1999 169 176
25. C. Cobbaert, L. Deprost, P. Mulder, K. Rombaut, G. Gijsels, and H. Kestleloot Pubertal serum Lp(a) and its correlates in Belgian schoolchildren Int J Epidemiol 24 1995 78 87
26. G. Kostner, G. Klein, and F. Krempler Can serum Lp(a) concentrations be lowered by drugs and/or diet? L. Carlson A. Olsson Treatment of Hyperlipoproteinemia 1984 Raven Press New York 151 160
27. A.J. Jenkins, J.S. Steele, E.D. Janus, and J.D. Best Increased plasma apolipoprotein (a) levels in IDDM patients with microalbuminuria Diabetes 40 1991 787 790
28. R.A. Lobo, M. Notelovitz, L. Bernstein, F.Y. Khan, R.K. Ross, and W.L. Paul Lp(a) lipoprotein: Relationship to cardiovascular disease risk factors, exercise, and estrogen Am J Obstet Gynecol 166 1992 1182 1190
29. G. De Pergola, F. Giorgino, M.R. Cospite, V.A. Giagulli, M. Cignarelli, and G. Ferri Relation between sex hormones and serum lipoprotein and lipoprotein (a) concentrations in premenopausal obese women Arterioscler Thromb 13 1993 675 679
30. J.P. Corsetti, J.A. Sterry, J.D. Sparks, C.E. Sparks, and M. Weintraub Effect of weight loss on serum lipoprotein(a) concentrations in an obese population Clin Chem 37 1991 1191 1195
31. National Institute of Diabetes and Digestive and Kidney Diseases The Cherokee Diabetes Study Operations Manual 1999 The Cherokee Diabetes Study Office, University of Oklahoma Health Science Center Oklahoma City, OK
32. W.J. Sobey, S.F. Beer, C.A. Carrington, P.M. Clark, B.H. Frank, and I.P. Gray Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins Biochem J 260 1989 535 541
33. C.S. Wang, P. Alaupovic, R.E. Gregg, and H.B. Brewer Jr. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes Biochimica et Biophysica Acta 920 1987 9 19
34. Lipid Research Program: Manual of laboratory operations. Vol. 1. Lipid and Lipoprotein Analysis. DHEW Publication number (NIH) 75-628 1974 National Institute of Health Bethesda, MD
35. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
36. M.D. Curry, P. Alaupovic, and C.A. Suenram Determination of apolipoprotein-A and its constitutive AI and AII polypeptides by separate electroimmunoassays Clinical Chemistry 22 1976 315 322
37. M.D. Curry, A. Gustafson, P. Alaupovic, and W.J. McConathy Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B Clin Chem 24 1978 280 286
38. 3H] cholesteryl linoleyl ether-labeled human Lp(a) in different rat organs Biochimica et Biophysica Acta 963 1988 534 540
39. The Export Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Export Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1997 1183 1197
40. T.K. Welty, E.T. Lee, J. Yeh, L.D. Cowan, O. Go, and R.R. Fabsitz Cardiovascular disease risk factors among American Indians: The Strong Heart Study Am J Epidemiol 142 1995 269 287
41. L.B. Houtkooper, S.B. Going, T.G. Lohman, A.F. Roche, and M. VanLoan Bioelectrical impedance estimation of fat-free body mass in children and youth: A cross-validation study J Appl Physiol 72 1992 366 373
42. S.R. Srinivasan, G.H. Dahlen, R.A. Jarpa, L.S. Webber, and G.S. Berenson Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children: Bogalusa Heart Study Circulation 84 1991 160 167
43. Wang Wenyu, Hu Dongsheng, E.T. Lee, R.R. Fabsitz, T.K. Welty, and D.C. Robbins Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease - The Strong Heart Study Ann Epidemiol 12 2002 107 114
44. J.L. Jenner, J.M. Ordovas, S. Lamon-Fava, M.M. Schaefer, P.W.F. Wilson, and W.P. Castelli Effects for age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study Circulation 87 1993 1135 1141
45. J.P. Werba, O. Safa, G. Gianfrancheschi, S. Michelagnoli, C.R. Sirtori, and G. Franceschini Plasma triglycerides and lipoprotein(a): Inverse relationship in a hyperlipidemic Italian population Atherosclerosis 101 1993 203 211
46. J. Genest, J.L. Jenner, J.R. McNamara, J.M. Ordovas, S.R. Silberman, and P.W.F. Wilson Prevalence of lipoprotein(a) excess in coronary artery disease Am J Cardiol 67 1991 1039 1045
47. H. Nakata, K. Horita, and M. Eto Alteration of lipoprotein(a) concentration with glycemic control in non-insulin-dependent diabetic subjects without diabetic complications Metabolism 42 1993 1323 1326
48. J.S. Cohn, C.W. Lam, D.R. Sullivan, and W.J. Hensley Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states Atherosclerosis 90 1991 59 66